Literature DB >> 35960545

Introduction and Differential Diagnosis of Monkeypox in Argentina, 2022.

Adrian Lewis, Alejandro Josiowicz, Stella Maris Hirmas Riade, Monica Tous, Gustavo Palacios, Daniel M Cisterna.   

Abstract

We report detection of cases of monkeypox virus infection in Argentina in the context of a marked increase in confounding cases of atypical hand-foot-and-mouth syndrome caused by enterovirus coxsackie A6. We recommend performing an accurate differential virological diagnosis for exanthematous disease in suspected monkeypox cases.

Entities:  

Keywords:  A6; Argentina; Bolivia; atypical hand-foot-mouth syndrome; enterovirus coxsackie; monkeypox; sexually transmitted infections; viruses

Mesh:

Year:  2022        PMID: 35960545      PMCID: PMC9514367          DOI: 10.3201/eid2810.221075

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   16.126


Global surveillance of monkeypox cases has resulted in the detection of an increasing number of suspected cases in countries to which the disease is not endemic (). We report the results of a virological investigation of 9 suspected cases of monkeypox from Argentina (n = 6) and Bolivia (n = 3) detected during May 22–June 8, 2022. The investigation was conducted using World Health Organization case definitions (). We attempted laboratory diagnosis for all 9 cases by using classical and molecular methods such as electron microscopy (EM) and conventional orthopoxvirus PCR. We analyzed swab samples collected from the skin, genital lesions, or both for monkeypox screening. We performed negative staining electron microscopy using direct absorption for 10 minutes of a 10-μL sample volume on fomvar-coated 400 mesh grids. We performed staining with 1% phosphotungstic acid () and examined samples using a Zeiss EM-109 transmission electron microscope. We extracted viral nucleic acid by using the High Pure Viral RNA kit (Roche Molecular Biochemicals, https://www.roche.com) according to the manufacturer’s instructions. We performed end-point PCR amplification by using primers EACP1 and EACP2 targeting the complete viral hemagglutinin gene, as done previously (). We sequenced amplicon PCR fragments by using BigDye Terminator version 3.1 reagent in an ABI3500 Genetic Analyzer automatic sequencer (both ThermoFisher Scientific, https://www.thermofisher.com). We performed phylogenetic analysis by using the maximum-likelihood method and Tamuka 3-parameter model according to Modeltest using MEGA software (https://www.megasoftware.net). We produced bootstraps using 500 replicates. For differential diagnosis, we analyzed negative monkeypox virus (MPXV) samples by molecular methods for the detection of herpes simplex virus, varicella zoster virus, and enterovirus. We performed molecular typing of enteroviruses as previously reported (). The images obtained by EM in cases 1–3, all from Argentina, showed the presence of viral particles compatible with a member of the genus Orthopoxvirus (Appendix Figure 1). The phylogenetic analysis of the complete hemagglutinin genes for these viruses confirmed the identification of MPXV (West African clade) (Appendix Figure 2). Enterovirus was identified by PCR in 4 (66.7%) of the remaining 6 cases (2 from Argentina and 2 from Bolivia). Coxsackievirus A6 (CV-A6) was identified in 3 of these 4 cases. CV-A6 is usually associated with atypical hand-foot-mouth syndrome. Finally, the 6 samples analyzed were negative for herpes simplex virus and varicella zoster virus. In summary, of the 9 cases from South America with exanthematic disease that fit the definition of suspected cases, 3 (33%) cases were confirmed for MPXV and 4 (44%) cases were differentially diagnosed as CV-A6 infections. We evaluated the clinical manifestations of all 9 cases. In the 3 laboratory-confirmed cases of MPXV, clinical manifestations included pustular lesions of heterogeneous distribution in the body, multiple painful intergluteal and perianal lesions, and genital ulcers (Table). All 3 patients reported multiple sexual partners during the previous few weeks, 2 during international travel to Spain and 1 with international travelers from countries reporting cases. No patients experienced lymphadenopathy. Patients 1 and 3 were hospitalized briefly for pain management related to their symptoms.
Table

Characteristics of suspected cases of monkeypox in Argentina and Bolivia*

Patientno.Age, y/sexClinical manifestationsCountryTravelhistoryHospitaladmissionBackgroundMPXVPCREV PCR/EV typeHSVPCRVZVPCR
1
40/M
Pustular lesions on the left shoulder, sternal, cervical, right scapula, left lower limb, multiple painful intergluteal and perianal lesions
Argentina
Spain
Yes
Multiple sexual partners, HIV+
+
ND
ND
ND
2
40/M
Genital ulcer
Argentina
Spain
No
Multiple sexual partners
+
ND
ND
ND
3
36/M
Fever, headache, myalgia, back pain, maculopapular lesions and pustules
Argentina
No reported travel
Yes
Multiple sexual partners
+
ND
ND
ND
4
36/M
Vesicular lesions on 
the palms, soles, 
and perineum
Argentina
Dominican Republic
No
3-year-old son with blistering lesion on the perineum




5
43/M
Fever, maculopapular lesions and pustules
Argentina
Paraguay
No
No data

+/CV-A6


6
39/F
Vesicular lesions 
on hand, mouth, 
and groin area
Argentina
Dominican Republic and Colombia
No
No data

+/CV-A6


7
53/F
Exanthematous lesions of unspecified distribution, lymphadenopathy
Bolivia
No reported travel
No
No data




8
22/F
Exanthematous lesions of unspecified distribution, lymphadenopathy
Bolivia
Spain
No
No data

+/CV-A6


927/MExanthematous lesions of unspecified distribution, lymphadenopathyBoliviaNo reported travelNoHIV++/ND

*CV-A6, coxsackievirus A6; EV, enterovirus; HSV, herpes simplex virus; MPXV, monkeypox virus; ND, not done; VZV, varicella zoster virus; +, positive; –, negative.

*CV-A6, coxsackievirus A6; EV, enterovirus; HSV, herpes simplex virus; MPXV, monkeypox virus; ND, not done; VZV, varicella zoster virus; +, positive; –, negative. The remaining 6 patients who were negative for orthopoxvirus displayed vesicular lesions in various stages on the palms, soles, and genital locations. Some reported travel from the Dominican Republic, Colombia, Paraguay, or Spain. The epidemiologic information we collected on these monkeypox cases, together with genetic analysis, confirm that they are directly related to outbreaks in several countries in Europe () and are not linked to previous introductions in the United States (; C.M. Gigante et al., unpub. data, https://www.biorxiv.org/content/10.1101/2022.06.10.495526v1). Although 1 patient did not travel, he reported direct physical contact with persons who had traveled to countries with reported cases, revealing local community transmission. Of note, South America is experiencing a marked increase in cases of atypical hand-foot-mouth syndrome caused by CV-A6 (,). Unlike the classic syndrome, this atypical variant also affects young adults and occurs in unusual regions of the body, including the genital areas, and could easily be confused with monkeypox. A wide case definition makes surveillance easier, but it also emphasizes the need to perform precise differential virological diagnosis for exanthematic disease in suspected cases. In summary, we report 3 cases of monkeypox in patients in Argentina. Six additional patients in Argentina and Bolivia had monkeypox ruled out by differential diagnosis; 4 of those cases were atypical hand-foot-mouth syndrome caused by CV-A6. We recommend considering virological diagnosis of this disease in suspected cases of monkeypox. Clinicians should be aware of the possibility for misdiagnosis related to these viral infections.

Appendix

Additional information about introduction and differential diagnosis of monkeypox in Argentina, 2022
  8 in total

1.  Atypical hand, foot, and mouth disease caused by Coxsackievirus A6 in Argentina in 2015.

Authors:  Daniel M Cisterna; Cristina L Lema; Leila M Martinez; Elizabeth Verón; Lorena P Contarino; Denise Acosta; María Cecilia Freire
Journal:  Rev Argent Microbiol       Date:  2018-09-27       Impact factor: 1.852

2.  Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.

Authors:  Andrea Antinori; Valentina Mazzotta; Serena Vita; Fabrizio Carletti; Danilo Tacconi; Laura Emma Lapini; Alessandra D'Abramo; Stefania Cicalini; Daniele Lapa; Silvia Pittalis; Vincenzo Puro; Marco Rivano Capparuccia; Emanuela Giombini; Cesare Ernesto Maria Gruber; Anna Rosa Garbuglia; Alessandra Marani; Francesco Vairo; Enrico Girardi; Francesco Vaia; Emanuele Nicastri
Journal:  Euro Surveill       Date:  2022-06

3.  Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022.

Authors:  Mariana Perez Duque; Sofia Ribeiro; João Vieira Martins; Pedro Casaca; Pedro Pinto Leite; Margarida Tavares; Kamal Mansinho; Luís Miguel Duque; Cândida Fernandes; Rita Cordeiro; Maria José Borrego; Ana Pelerito; Isabel Lopes de Carvalho; Sofia Núncio; Vera Manageiro; Corrado Minetti; Jorge Machado; Joana M Haussig; Roberto Croci; Gianfranco Spiteri; Ana Sofia Casal; Diana Mendes; Tiago Souto; Sara Pocinho; Teresa Fernandes; Ana Firme; Paula Vasconcelos; Graça Freitas
Journal:  Euro Surveill       Date:  2022-06

4.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

5.  Hand-foot-and-mouth disease in uruguay: Coxsackievirus A6 identified as causative of an outbreak in a rural childcare center.

Authors:  Andrés Lizasoain; Sofia Piegas; Matías Victoria; Edson E Da Silva; Rodney Colina
Journal:  J Med Virol       Date:  2019-09-20       Impact factor: 2.327

6.  Detection limit of negative staining electron microscopy for the diagnosis of bioterrorism-related micro-organisms.

Authors:  M Laue; N Bannert
Journal:  J Appl Microbiol       Date:  2010-08-19       Impact factor: 3.772

7.  Coxsackievirus A6 strains causing an outbreak of hand-foot-and-mouth disease in Northeastern Brazil in 2018.

Authors:  Adriana Luchs; Lais Sampaio de Azevedo; Ellen Viana de Souza; Roberta Salzone Medeiros; Yasmin França Viana Pires de Souza; Dalane Loudal Florentino Teixeira; Thiago Franco de Oliveira Carneiro; Gabriela Maria Fernandes de Alencar; Fernanda Lúcia de Sousa Leite Morais; Diana de Fátima Alves Pinto; Thelma Suely Okay; Lidia Yamamoto; Vanessa Dos Santos Morais; Emerson Luiz Lima Araújo; Elcio Leal; Antonio Charlys da Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-02-21       Impact factor: 1.846

8.  The changing epidemiology of human monkeypox-A potential threat? A systematic review.

Authors:  Eveline M Bunge; Bernard Hoet; Liddy Chen; Florian Lienert; Heinz Weidenthaler; Lorraine R Baer; Robert Steffen
Journal:  PLoS Negl Trop Dis       Date:  2022-02-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.